Innovative healthcare and biotech companies
Innovative healthcare and biotech companies
Sector rotation strategies are rooted in business cycle analysis, drawing on the work of Wesley Mitchell at the National Bureau of Economic Research (founded 1920). Sam Stovall's 'Standard & Poor's Guide to Sector Investing' formalized the link between economic cycles and sector performance. Martin Pring's intermarket analysis and the research of Fidelity's sector fund team under Peter Lynch further developed sector-based investment frameworks. The Global Industry Classification Standard (GICS) by MSCI and S&P provides the modern taxonomy for sector analysis.
Tap to view the AI-generated insight
Higher-risk profile — expect large swings and deep drawdowns in pursuit of outsized returns.
Stocks currently selected by this strategy's screen, ordered by how many of its criteria they meet.
The screening engine hasn't matched stocks to this strategy's criteria yet. Check back after the next weekly screen.
Important disclaimer
Backtested KPIs are estimates derived from historical data and do not guarantee future returns. Markets carry risk of loss.
Which strategies led this month — real backtest data, once a month, no spam.
Unsubscribe anytime. We never share your email.